Recent Articles from MarketBeat
MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
Website: https://www.marketbeat.com
Insiders Are Selling These 5 AI Stocks—Should You Worry?insidertrades.com
Insiders at CoreWeave, Arista Networks, Dell, Snowflake and NVIDIA have been selling shares, but analyst ratings, institutional buying and fundamentals suggest the AI trade's outlook remains largely intact.
Via MarketBeat · October 26, 2026
Buy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big Catalystsmarketbeat.com
MercadoLibre, Novo Nordisk, Tyler Technologies and Summit Therapeutics trade below recent highs, yet each has earnings or catalysts that could shift sentiment.
Via MarketBeat · October 26, 2026
Range Resources to Join EQT in $50B Appalachian Gas Dealmarketbeat.com
EQT Corp. announced an agreement to acquire Range Resources (NYSE:RRC) in an all-stock transaction that the companies said would create a larger, vertically integrated Appalachian natural gas platform focused on serving anticipated growth in domestic power generation, pipeline takeaway and internati
Via MarketBeat · October 26, 2026
Verizon Communications Q3 Earnings Call Highlightsmarketbeat.com
Verizon Communications (NYSE:VZ) reported stronger third-quarter operating and financial results, citing growth in postpaid wireless accounts, lower customer-acquisition costs, accelerating service-revenue growth and rising free cash flow. The company raised several elements of its 2026 outlook and
Via MarketBeat · October 26, 2026
What Alliance Resource Partners (ARLP) Said on Its Q3 Earnings Callmarketbeat.com
Alliance Resource Partners (NASDAQ:ARLP) reported higher third-quarter 2026 revenue, earnings and adjusted EBITDA, supported by stronger coal shipments, the return of longwall production at its Hamilton mine and the first full-quarter contribution from its AllDale III and IV oil-and-gas royalty acqu
Via MarketBeat · October 26, 2026
Amur Minerals H1 Earnings Call Highlightsmarketbeat.com
Airtel Money reported strong first-half growth in its first results presentation since listing on the London Stock Exchange, with revenue rising 34% in reported currency to $830 million and 25.1% in constant currency.
The mobile financial services provider, which operates across 13 markets in East
Via MarketBeat · October 26, 2026
3 Companies With Room to Pass on Costs to Manage Inflationmarketbeat.com
As inflation accelerates, WD-40, Balchem, and Interparfums show pricing power and sales resilience despite rising chemical, freight, and logistics costs pressuring margins.
Via MarketBeat · October 26, 2026
EQT to Acquire Range Resources in $50B Natural Gas Powerhouse Dealmarketbeat.com
EQT (NYSE:EQT) announced an agreement to acquire Range Resources in an all-stock transaction that the companies said would create a larger integrated natural gas producer with expanded Appalachian Basin inventory, infrastructure access and marketing capabilities.
Under the agreement, Range sharehol
Via MarketBeat · October 26, 2026
What Medifast (MED) Said on Its Q3 Earnings Callmarketbeat.com
Medifast (NYSE:MED) reported third-quarter 2026 revenue of $72 million, down 19.4% from a year earlier, as the company continued to face a sharp decline in its active earning coach base. Management said revenue was within its guidance range and marked a fourth consecutive quarter in which sales stab
Via MarketBeat · October 26, 2026
MakeMyTrip Q2 Earnings Call Highlightsmarketbeat.com
MakeMyTrip (NASDAQ:MMYT) reported 20.9% year-over-year growth in second-quarter fiscal 2027 gross bookings on a constant-currency basis, reaching $2.7 billion, as growth in hotels, ground transportation and ancillary services helped offset pressure on air travel.
Co-Founder and Group CEO Rajesh Mag
Via MarketBeat · October 26, 2026
Not All Tech Is Getting Crushed: 5 Names Holding Up Through the AI Sell-Offmarketbeat.com
While chip stocks slide, cybersecurity and software names like HACK, IGV, Microsoft, CrowdStrike, and Palantir hold near highs, suggesting a rotation within tech rather than a broad exit.
Via MarketBeat · October 26, 2026
Actively Managed ETFs Are Giving In to the Price War—To the Benefit of Investorsmarketbeat.com
Low-fee active ETFs DFLV, DFAC, and USMC now rival passive funds on cost, but comparisons with Vanguard alternatives show mixed performance and liquidity trade-offs for investors.
Via MarketBeat · October 26, 2026
Valero’s Windfall Quarter Meets Washington’s Push for Cheaper Dieselmarketbeat.com
Valero posted record Q3 revenue and EPS on soaring refining margins, but shares sold off on light Q4 guidance and concerns over Russian diesel imports and crude price pressure.
Via MarketBeat · October 26, 2026
Acumen Pharmaceuticals Q3 Earnings Call Highlightsmarketbeat.com
Acumen Pharmaceuticals (NASDAQ:ABOS) said it expects to report top-line results in November from its Phase II ALTITUDE-AD trial of sabirnetug, an investigational antibody designed to target soluble amyloid-beta oligomers in patients with Alzheimer’s disease.
Chief Executive Officer Dan O’Connell sa
Via MarketBeat · October 26, 2026
Lockheed Martin, Interactive Brokers, AEP Hike Dividends on Strong Growthdividendstocks.com
Lockheed Martin, Interactive Brokers and American Electric Power raised dividends, with payout ratios near or below 60% pointing to sustainable future increases.
Via MarketBeat · October 26, 2026
4 Small-Cap Stocks With Paths to Recovery After the Fed's September Rate Hikemarketbeat.com
Amid a Russell 2000 sell-off driven by rising rates, FIBK, EPAC, CCS, and HRMY show varied resilience, with analysts weighing risks against potential upside in each stock.
Via MarketBeat · October 26, 2026
A 70% Rally Isn't Chord Energy's Only Selling Pointmarketbeat.com
Chord Energy shares have surged over 70% in 2026 on higher oil prices and strong free cash flow, fueling dividends and buybacks ahead of its Nov. 4 earnings report.
Via MarketBeat · October 26, 2026
Broadcom's AI Chip Business Is Booming, But Alphabet's Strategy Highlights 2 Key Risksmarketbeat.com
Broadcom faces rising competition as Alphabet diversifies its TPU suppliers to MediaTek, though growing Anthropic and OpenAI demand could offset this risk to AVGO's AI chip growth.
Via MarketBeat · October 26, 2026
Amazon's $350 Price Target Faces a Big Earnings Testmarketbeat.com
Morgan Stanley named Amazon its Top Pick with a $350 target, citing AWS growth, but shares have slipped ahead of the Oct. 29 earnings report amid AI spending worries.
Via MarketBeat · October 26, 2026
NORMA Group Unveils New Strategy Targeting 10%+ EBIT Margin by 2031marketbeat.com
NORMA Group (ETR:NOEJ) outlined its “New NORMA” strategy at its first capital markets day since the company’s 2011 initial public offering, setting targets for profitable growth, margin expansion and cash generation through 2031.
Chief Executive Officer Birgit Seeger said the company is reorganizin
Via MarketBeat · October 25, 2026
Rapport Therapeutics’ RAP-219 Hits Phase II Goals in Bipolar Mania Trialmarketbeat.com
Rapport Therapeutics (NASDAQ:RAPP) reported positive top-line results from a Phase II proof-of-concept trial of RAP-219 in adults with acute bipolar mania, meeting both its primary and secondary endpoints and supporting plans to advance the candidate into Phase III development.
The three-week, plac
Via MarketBeat · October 25, 2026
Newmont’s Record Quarter Shows Why Gold’s Floor Is the Real Storymarketbeat.com
Newmont posted record Q3 adjusted earnings of $2.20 per share as gold held near a $4,000 floor, with improved cost guidance, strong free cash flow, buybacks, and dividends.
Via MarketBeat · October 25, 2026
Odyssey Therapeutics Highlights OD-001 Phase IIa UC Data, Sets 2027 Trial Readoutsmarketbeat.com
Odyssey Therapeutics (NASDAQ:ODTX) presented additional data from its open-label Phase IIa trial of OD-001, an oral RIPK2 scaffolding inhibitor for moderate-to-severe ulcerative colitis, during its UEG Week 2026 investor webcast. The company said the complete induction dataset, biomarker findings an
Via MarketBeat · October 25, 2026
Albemarle Upgrade: Can Energy Storage Recharge Lithium’s Leader?marketbeat.com
Mizuho upgraded Albemarle to Outperform with a $130 target, citing battery storage demand and low-cost production ahead of its Nov. 4 earnings report.
Via MarketBeat · October 25, 2026
Aclara Resources Targets Rare-Earth Supply Chain From South America to Louisianamarketbeat.com
Aclara Resources (TSE:ARA) outlined plans to build an integrated rare-earth supply chain spanning two ionic-clay deposits in South America, a separation facility in Louisiana and a metals-and-alloys operation, with management emphasizing its focus on heavy rare earth elements including dysprosium, t
Via MarketBeat · October 25, 2026
Consumer Staples Are Up 12% This Year—These 3 Beverage Stocks Are Leading the Waymarketbeat.com
Coca-Cola, Monster Beverage, and Keurig Dr. Pepper have each gained at least 20% YTD as beverages lead a consumer staples rebound, with all three reporting Q3 2026 earnings soon.
Via MarketBeat · October 25, 2026
Lexeo Therapeutics Maps Gene Therapy Milestones, Eyes Key 2027 Readoutmarketbeat.com
Lexeo Therapeutics (NASDAQ:LXEO) outlined upcoming clinical and regulatory milestones for its gene therapy programs in Friedreich’s ataxia cardiomyopathy and PKP2-associated arrhythmogenic cardiomyopathy during the Chardan Healthcare Conference.
Chief Financial Officer Lou Tamayo said the clinical-
Via MarketBeat · October 25, 2026
Can Planet Fitness Get Its Growth Back in Shape?marketbeat.com
Planet Fitness shares have slumped amid slowing membership growth and AI-related concerns, but analysts see over 30% upside ahead of third-quarter earnings on Nov. 5.
Via MarketBeat · October 25, 2026
3 Defined Outcome ETFs Offering Unique Twists on Buffer Strategiesmarketbeat.com
New defined outcome ETFs QBKV, SBAR, and XX offer varied buffer, income, and leveraged strategies tied to small caps, options income, and the S&P 500, each with distinct costs and risks.
Via MarketBeat · October 25, 2026
Opus Genetics Eyes 2029 Runway as Presbyopia Drop Wins FDA Approvalmarketbeat.com
Opus Genetics (NASDAQ:IRD) outlined commercialization expectations for its newly approved presbyopia eye drop, progress across its inherited retinal disease gene therapy pipeline and its funding strategy during an investor panel featuring Chief Executive Officer Dr. George Magrath and Chief Financia
Via MarketBeat · October 25, 2026
Market Volatility Playbook: Trade the Noise, Get Paid to Ignore the Restmarketbeat.com
Monument Traders Alliance strategists detail a volatility-trading sleeve using IWM, QQQ and GLD options alongside longer-term holdings in Agnico Eagle Mines and Nuveen Municipal Value Fund for income.
Via MarketBeat · October 25, 2026
Deep Fission Targets 2027 Kansas Nuclear Pilot, 2028 Commercial Rolloutmarketbeat.com
Deep Fission (NASDAQ:FISN) outlined its development, regulatory and financing plans for underground nuclear power projects during its October 2026 business update, targeting initial commercial power from a pilot project in Parsons, Kansas, by December 2027 and broader deployments beginning in 2028.
Via MarketBeat · October 25, 2026
Adagene Eyes Phase II Data for Masked CTLA-4 Therapy in MSS Colorectal Cancermarketbeat.com
Adagene (NASDAQ:ADAG) is advancing its masked anti-CTLA-4 antibody, ADG126, also known as muzastotug, in metastatic microsatellite-stable colorectal cancer (MSS CRC) and in a neoadjuvant investigator-sponsored trial in Singapore, Chief Strategy Officer Mickael Chane-Du said during a Chardan conferen
Via MarketBeat · October 25, 2026
Capstone Energy+ Eyes Data Centers With ‘Energy Certainty’ Pushmarketbeat.com
Capstone Energy+ (NASDAQ:CEPL) is positioning its distributed energy technology as a way to provide “energy certainty” for customers facing grid constraints, permitting delays and growing power needs, President and CEO Vince Canino said during a company presentation.
Canino said businesses historic
Via MarketBeat · October 25, 2026
Palvella Therapeutics Eyes QTORIN Launch as Rare-Disease Pipeline Expandsmarketbeat.com
Palvella Therapeutics (NASDAQ:PVLA) is preparing for a potential commercial launch of QTORIN rapamycin while advancing additional rare skin and vascular anomaly programs, Chief Financial Officer Matt Korenberg said during a Chardan investor session.
Korenberg said the company has expanded from deve
Via MarketBeat · October 25, 2026
OmniAb Highlights $3B Milestone Pipeline, AI Antibody Platform at Conferencemarketbeat.com
OmniAb (NASDAQ:OABI) Chief Financial Officer Kurt Gustafson outlined the company’s antibody-discovery platform, partner pipeline and revenue model during a company presentation, emphasizing a strategy built around licensing technology to pharmaceutical and biotechnology companies rather than develop
Via MarketBeat · October 25, 2026
FitLife Brands Eyes Acquisitions, Margin Gains to Offset Organic Growth Headwindsmarketbeat.com
FitLife Brands (NASDAQ:FTLF) outlined its strategy to grow a portfolio of nutritional supplement and wellness brands through acquisitions, e-commerce sales and operational improvements, while acknowledging recent organic-growth headwinds tied to Amazon changes, specialty retail traffic and weakening
Via MarketBeat · October 24, 2026
Strawberry Fields REIT CEO Maps SNF Growth Strategy, 100% Rent Collection Recordmarketbeat.com
Strawberry Fields REIT (NYSEAMERICAN:STRW) Chairman, CEO and founder Moishe Gubin outlined the skilled nursing facility real estate investment trust’s growth strategy, lease structure and demographic outlook, emphasizing recurring rent collections and a disciplined acquisition model.
Gubin said the
Via MarketBeat · October 24, 2026
Amgen's IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer Studymarketbeat.com
Amgen (NASDAQ:AMGN) presented Phase III data at the European Society for Medical Oncology Congress 2026 showing that its DLL3-targeting BiTE therapy IMDELLTRA, when added to durvalumab maintenance treatment, improved survival outcomes for patients with extensive-stage small-cell lung cancer whose di
Via MarketBeat · October 24, 2026
Moderna Melanoma Therapy Cuts Recurrence Risk 42% in Phase 3 Trialmarketbeat.com
Moderna (NASDAQ:MRNA) presented Phase 3 results for intismeran, its individualized neoantigen therapy, in combination with Merck’s pembrolizumab for patients with resected high-risk melanoma. The INTerpath-001 trial met its primary endpoint of relapse-free survival and a key secondary endpoint of di
Via MarketBeat · October 24, 2026
Parabilis Highlights 72% Response Rate, Maps Phase III Desmoid Trial for 2027marketbeat.com
Parabilis Medicines (NASDAQ:PBLS) presented updated interim phase I/II data for investigational beta-catenin/TCF inhibitor zolucatetide in desmoid tumors at the European Society for Medical Oncology Congress in Madrid, reporting tumor responses, disease control and an FDA-aligned plan for a registra
Via MarketBeat · October 24, 2026
CitroTech Targets Wildfire Defense Growth With Hexion JV, CitroSafe Pushmarketbeat.com
CitroTech (NYSEAMERICAN:CITR) is positioning its citric-acid-derived fire-retardant technology for use in wildfire prevention, wood products and residential property protection, Chief Executive Officer Wes Bolsen said during a presentation at the LD Micro conference.
Bolsen, who became CEO about a
Via MarketBeat · October 24, 2026
Lotus Technology Targets EBIT Profitability Before 2030 as Deliveries, Margins Improvemarketbeat.com
Lotus Technology (NASDAQ:LOT) CFO Daxue Wang outlined the luxury automaker’s electrification strategy, first-half performance improvements and longer-term profitability targets during a company presentation.
Wang said Lotus, founded in 1948, is seeking to build on its heritage in Formula 1, sports
Via MarketBeat · October 24, 2026
BUDA Details Ultra Fresh Expansion, New Plants and Wholesale Growth Strategymarketbeat.com
BUDA (NYSEAMERICAN:BUDA) outlined its strategy to expand distribution of its “Ultra Fresh” juice and beverage products, emphasizing a wholesale model, a refrigerated supply chain and plans to add production capacity in the eastern and western United States.
During a company presentation, management
Via MarketBeat · October 24, 2026
Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipelinemarketbeat.com
Bloom Energy's Q3 revenue surged 138.9% and guidance rose again despite Oracle's force majeure notice, as backlog growth, new deals, and analyst upside offset dilution risks.
Via MarketBeat · October 24, 2026
MLP Raises 2026 EBIT Outlook After Record Q3 Performance Feesmarketbeat.com
MLP (ETR:MLP) CFO Reinhard Loose outlined the financial services group’s growth strategy, reported first-half gains across its three core business areas and raised the company’s 2026 EBIT outlook following stronger-than-expected performance fees in the third quarter.
Loose said MLP’s business model
Via MarketBeat · October 24, 2026
Why Western Digital's AI Storage Boom Defies the Chip Sell-Offmarketbeat.com
Western Digital shares fell amid a chip sell-off despite rising margins, revenue growth, and strong demand for its hard disk drives, as the company posted higher guidance and a dividend increase.
Via MarketBeat · October 24, 2026
Tharimmune Investor Update Spotlights Canton Network’s Tokenization Pushmarketbeat.com
Canton Strategic Holdings President Mark Toomey said institutional participation in the Canton Network continued to expand during the third quarter as infrastructure providers, asset issuers and market participants prepared for a planned late-October rollout by the Depository Trust & Clearing Co
Via MarketBeat · October 24, 2026
Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Dividedmarketbeat.com
Grand Canyon Education posts steady enrollment and earnings growth, extends its GCU services agreement through 2041, but faces a CFO leave of absence and ongoing regulatory scrutiny.
Via MarketBeat · October 24, 2026
FST Conference: KBS Golf Shaft Maker Swings to Profit as Revenue Rises 23%marketbeat.com
FST (NASDAQ:KBSX), a golf shaft manufacturer operating under the KBS brand, said it increased first-half revenue by 23% and gross profit by 33% year over year as it benefited from manufacturing scale and lower per-shaft production costs.
Speaking at a company presentation, Chief Financial Officer S
Via MarketBeat · October 24, 2026
Amex Stock Slides on Job Cuts, But the Real Story Is Macromarketbeat.com
American Express posted record Q3 2026 revenue, raised EPS guidance, and improved credit metrics, yet AXP stock fell as investors weighed job cuts and macro concerns.
Via MarketBeat · October 24, 2026
Chefs' Warehouse Has Rallied 76%—Can the Stock Keep Climbing?marketbeat.com
Chefs' Warehouse shares are up 76% in 2026 on strong sales and profit growth, but a rich valuation and limited analyst upside raise questions about the stock's run.
Via MarketBeat · October 24, 2026
MarketBeat Week in Review – 10/19 - 10/23marketbeat.com
A market sell-off spread beyond tech as oil prices surged and AI concerns grew. MarketBeat analysts recap the week's top stories on earnings, from Halliburton to Meta Platforms and General Motors.
Via MarketBeat · October 24, 2026
CapsoVision Maps AI Capsule Push Into Colon, Pancreatic Cancer Screeningmarketbeat.com
CapsoVision (NASDAQ:CV) outlined its strategy to expand capsule endoscopy technology beyond its current small-bowel business into colon, pancreatic and esophageal cancer screening applications, highlighting its artificial intelligence capabilities, cloud-based workflow and upcoming regulatory submis
Via MarketBeat · October 24, 2026
Lexeo Therapeutics Eyes NSVT Data as Key Test for LX2020 Gene Therapymarketbeat.com
Lexeo Therapeutics (NASDAQ:LXEO) outlined its approach to evaluating LX2020, an investigational AAVrh10-based gene therapy for PKP2-associated arrhythmogenic cardiomyopathy, or ACM, ahead of an expected clinical and regulatory update later this quarter.
CEO Nolan Townsend said PKP2 ACM is a serious
Via MarketBeat · October 24, 2026
BlockchAIn Digital Infrastructure Unveils $1B+ Nebius Data Center Lease Strategymarketbeat.com
BlockchAIn Digital Infrastructure (NYSEAMERICAN:AIB) outlined a data-center development strategy centered on smaller, power-secured facilities, long-term tenant contracts and project-level financing during a presentation by CFO Jolienne Halisky.
Halisky said the company views itself as a “right-siz
Via MarketBeat · October 24, 2026
Kits Eyecare Eyes Glasses-Led Growth as Margins Expand and Capacity Rampsmarketbeat.com
Kits Eyecare (TSE:KITS) is targeting further growth in the online optical market by expanding its higher-margin glasses business, increasing brand awareness through select physical locations and leveraging a manufacturing operation that management says has substantial unused capacity.
Speaking at a
Via MarketBeat · October 24, 2026
Vertex Highlights Kidney Pipeline as Povetacicept Cuts Proteinuria 52% in Phase IIImarketbeat.com
Vertex Pharmaceuticals (NASDAQ:VRTX) outlined updates across its kidney disease pipeline at the American Society of Nephrology Kidney Week 2026, highlighting data for povetacicept in IgA nephropathy and inaxaplin in APOL1-mediated kidney disease, or AMKD.
Chief Executive Officer and President Reshm
Via MarketBeat · October 23, 2026
Novartis Remibrutinib Cuts MS Relapses in Phase III, Eyes $4B Opportunitymarketbeat.com
Novartis (NYSE:NVS) presented Phase III results for remibrutinib in relapsing multiple sclerosis, reporting that the oral Bruton’s tyrosine kinase inhibitor reduced relapse rates and MRI lesion activity versus teriflunomide in the REMODEL-1 and REMODEL-2 studies.
The company said global regulatory
Via MarketBeat · October 23, 2026
Vinci Compass to Buy AustralRe, Launching Permanent Capital Solutionsmarketbeat.com
Vinci Compass Investments (NASDAQ:VINP) said it plans to launch Vinci Permanent Capital Solutions, or VPCS, through the acquisition of AustralRe, a Latin American reinsurance platform that Vinci helped found in 2011.
The transaction is expected to close in the first quarter of 2027, subject to regu
Via MarketBeat · October 23, 2026
First Phosphate Targets 2030 Quebec Mine Production With 2027 Feasibility Studymarketbeat.com
First Phosphate (NASDAQ:PHOS) is advancing a proposed igneous phosphate mining project in northern Quebec, with a feasibility study targeted for the first quarter of 2027 and initial production envisioned by 2030, President Armand MacKenzie said during a company presentation.
MacKenzie, who said he
Via MarketBeat · October 23, 2026
Perspective Therapeutics Posts 72% 18-Month PFS in VMT-α-NET Study Updatemarketbeat.com
Perspective Therapeutics (NYSEAMERICAN:CATX) presented updated clinical data for its VMT-α-NET program at the European Society for Medical Oncology Congress 2026, reporting tumor responses, an 18-month progression-free survival landmark rate of 72% across three cohorts and no dose-limiting toxicitie
Via MarketBeat · October 23, 2026
Preferred Bank Q3 Earnings Call Highlightsmarketbeat.com
Preferred Bank (NASDAQ:PFBC) reported third-quarter 2026 net income of $32.9 million, or $2.73 per share, as deposit growth and continued expense control were partly offset by a reversal of interest income and ongoing delays in resolving nonaccrual loans.
Chairman and CEO Li Yu said the quarter was
Via MarketBeat · October 23, 2026
Kilroy Realty Q3 Earnings Call Highlightsmarketbeat.com
Kilroy Realty (NYSE:KRC) reported third-quarter leasing activity that management described as its strongest in years, driven by broad demand across its West Coast office and life science markets. The company signed approximately 815,000 square feet of new and renewal leases during the quarter, lifti
Via MarketBeat · October 23, 2026
What Banco Bradesco (BBD) Said on Its Q3 Earnings Callmarketbeat.com
Banco Bradesco (NYSE:BBD) said it completed a BRL 10 billion capital increase and reported continued loan growth, higher revenue across several business lines and progress in its operating-efficiency and digital-transformation initiatives during its third-quarter earnings call.
Marcelo Noronha said
Via MarketBeat · October 23, 2026
Canopy Growth Shareholders Approve Reverse Split Authority, Elect Boardmarketbeat.com
Canopy Growth (NASDAQ:CGC) shareholders approved all matters presented at the company’s reconvened 2026 Annual General and Special Meeting, including a share-consolidation authorization, the election of five directors and the appointment of MNP LLP as auditor for fiscal 2027.
The virtual meeting, w
Via MarketBeat · October 23, 2026
What WSFS Financial (WSFS) Said on Its Q3 Earnings Callmarketbeat.com
WSFS Financial (NASDAQ:WSFS) reported third-quarter 2026 core earnings per share of $1.75, with core return on assets of 1.58% and core return on tangible common equity of 20.7%, Chief Financial Officer David Burg said during the company’s earnings call. Each measure increased from the prior quarter
Via MarketBeat · October 23, 2026
First Hawaiian Q3 Earnings Call Highlightsmarketbeat.com
First Hawaiian (NASDAQ:FHB) said its third-quarter results reflected higher net interest income, lower deposit costs and continued deposit growth, while credit metrics were affected by a charge-off tied to a downtown Seattle office property and several commercial real estate downgrades.
Chairman, P
Via MarketBeat · October 23, 2026
What Corporacion Inmobiliaria Vesta (VTMX) Said on Its Q3 Earnings Callmarketbeat.com
Corporacion Inmobiliaria Vesta (NYSE:VTMX) reported record new leasing activity in the third quarter of 2026, higher occupancy and double-digit growth in rental revenue, prompting the Mexican industrial real estate company to raise its full-year outlook.
Chief Executive Officer Lorenzo Dominique Be
Via MarketBeat · October 23, 2026
What Comfort Systems USA (FIX) Said on Its Q3 Earnings Callmarketbeat.com
Comfort Systems USA (NYSE:FIX) reported sharply higher third-quarter results, supported by strong demand in construction activity, particularly from technology and industrial customers, and continued growth in its electrical and modular operations.
The company earned net income of $489 million, or
Via MarketBeat · October 23, 2026
Dr. Reddy's Laboratories Q2 Earnings Call Highlightsmarketbeat.com
Dr. Reddy's Laboratories (NYSE:RDY) reported second-quarter FY2027 revenue of INR 8,671 crore, or $905 million, down 1.5% from a year earlier but up 7.4% sequentially, as lower North American lenalidomide sales offset growth in its underlying business.
Chief Financial Officer M.V. Narasimham said t
Via MarketBeat · October 23, 2026
Byline Bancorp Q3 Earnings Call Highlightsmarketbeat.com
Byline Bancorp (NYSE:BY) reported record third-quarter net income and revenue, expanded its net interest margin and increased deposits, while also announcing an agreement to acquire Illinois State Bancorp and raising its quarterly dividend.
Net income for the third quarter was $41.8 million, or $0.
Via MarketBeat · October 23, 2026
What First Western Financial (MYFW) Said on Its Q3 Earnings Callmarketbeat.com
First Western Financial (NASDAQ:MYFW) reported third-quarter 2026 net income of approximately $6 million, or $0.60 per diluted share, as loan growth, net interest margin expansion, improving deposit mix and expense controls supported profitability.
Chairman and Chief Executive Officer Scott Wylie s
Via MarketBeat · October 23, 2026
What First Bank (FRBA) Said on Its Q3 Earnings Callmarketbeat.com
First Bank (NASDAQ:FRBA) reported third-quarter 2026 net income of $12.2 million, or $0.49 per diluted share, as higher net interest income, loan growth and operating discipline supported improved profitability.
President and CEO Patrick Ryan said loans increased $50 million during the quarter whil
Via MarketBeat · October 23, 2026
Oric Pharmaceuticals’ Enozertinib Shows 88% Response Rate in EGFR Lung Cancer Studymarketbeat.com
Oric Pharmaceuticals (NASDAQ:ORIC) reported updated Phase 1b data for enozertinib in previously untreated patients with advanced non-small cell lung cancer (NSCLC) carrying atypical EGFR mutations, highlighting systemic and intracranial responses in a cohort with a high prevalence of baseline brain
Via MarketBeat · October 23, 2026